Aktis Oncology (AKTS)

Aktis Oncology (AKTS) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• AKTS last traded at $14.59, -8.41% on the day.
• Aktis Oncology: market cap $886.02M, P/E -13.9, revenue $10.06M over the last four quarters, next earnings 2026-11-12.

Updated 2026-11-03 13:26 UTC